Palmitelaidic acid-d13

Palmitelaidic acid-d13 is the deuterium labeled Palmitelaidic Acid. Palmitelaidic Acid (9-trans-Hexadecenoic acid) is the trans isomer of palmitoleic acid. Palmitoleic acid is one of the most abundant fatty acids in serum and tissue.

Product Specifications

CAS Number

[2692623-91-7]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

AMPK; Glucokinase; Isotope-Labeled Compounds; PPAR

Type

Isotope-Labeled Compounds

Related Pathways

Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease; Others; PI3K/Akt/mTOR; Vitamin D Related/Nuclear Receptor

Field of Research

Metabolic Disease

Concentration

37.38 mM * 100 μL in Ethanol

Purity

99.0

Solubility

10 mM in DMSO

Smiles

[2H]C([2H])(C([2H])(C([2H])(C([2H])(C([2H])(C([2H])(/C=C/CCCCCCCC(O)=O)[2H])[2H])[2H])[2H])[2H])[2H]

Molecular Formula

C16H17D13O2

Molecular Weight

267.49

Precautions

H302, H315, H319, H335

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Frigolet ME, et al. The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease.|[3]de Souza CO, et al. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation. J Cell Physiol. 2016 Dec 7. doi: 10.1002/jcp.25715.|[4]Yang ZH, et al. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 2011 Jul 21;10:120.